Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 3
2022 5
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides.
Ermini E, Brai A, Cini E, Finetti F, Giannini G, Padula D, Paradisi L, Poggialini F, Trabalzini L, Tolu P, Taddei M. Ermini E, et al. Among authors: poggialini f. Chem Sci. 2024 Apr 2;15(16):6168-6177. doi: 10.1039/d4sc01576b. eCollection 2024 Apr 24. Chem Sci. 2024. PMID: 38665538 Free PMC article.
A Facile Access to Green Fluorescent Albumin Derivatives.
Saletti M, Paolino M, Venditti J, Bonechi C, Giuliani G, Lamponi S, Tassone G, Boccia A, Botta C, Blancafort L, Poggialini F, Vagaggini C, Cappelli A. Saletti M, et al. Among authors: poggialini f. Chembiochem. 2024 Apr 16;25(8):e202300862. doi: 10.1002/cbic.202300862. Epub 2024 Mar 13. Chembiochem. 2024. PMID: 38369609
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment.
Vagaggini C, Petroni D, D'Agostino I, Poggialini F, Cavallini C, Cianciusi A, Salis A, D'Antona L, Francesconi V, Manetti F, Damonte G, Musumeci F, Menichetti L, Dreassi E, Carbone A, Schenone S. Vagaggini C, et al. Among authors: poggialini f. Drug Dev Res. 2024 Feb;85(1):e22158. doi: 10.1002/ddr.22158. Drug Dev Res. 2024. PMID: 38349262
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth.
Maresca L, Crivaro E, Migliorini F, Anichini G, Giammona A, Pepe S, Poggialini F, Vagaggini C, Giannini G, Sestini S, Borgognoni L, Lapucci A, Dreassi E, Taddei M, Manetti F, Petricci E, Stecca B. Maresca L, et al. Among authors: poggialini f. Pharmacol Res. 2023 Sep;195:106858. doi: 10.1016/j.phrs.2023.106858. Epub 2023 Jul 19. Pharmacol Res. 2023. PMID: 37473878 Free article.
Progress towards Adjuvant Development: Focus on Antiviral Therapy.
Brai A, Poggialini F, Pasqualini C, Trivisani CI, Vagaggini C, Dreassi E. Brai A, et al. Among authors: poggialini f. Int J Mol Sci. 2023 May 25;24(11):9225. doi: 10.3390/ijms24119225. Int J Mol Sci. 2023. PMID: 37298177 Free PMC article. Review.
Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors.
Balestri LJI, Trivisani CI, Orofino F, Fiorucci D, Truglio GI, D'Agostino I, Poggialini F, Botta L, Docquier JD, Dreassi E. Balestri LJI, et al. Among authors: poggialini f. ACS Med Chem Lett. 2023 Mar 21;14(4):417-424. doi: 10.1021/acsmedchemlett.2c00472. eCollection 2023 Apr 13. ACS Med Chem Lett. 2023. PMID: 37077400 Free PMC article.
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme.
Poggialini F, Vagaggini C, Brai A, Pasqualini C, Crespan E, Maga G, Perini C, Cabella N, Botta L, Musumeci F, Frosini M, Schenone S, Dreassi E. Poggialini F, et al. Pharmaceutics. 2023 Jan 30;15(2):453. doi: 10.3390/pharmaceutics15020453. Pharmaceutics. 2023. PMID: 36839775 Free PMC article.
20 results